| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| KLS-2031 | KLS-2031 | Phase 2 Clinical | Kolon Life Science. Inc | Radiculopathy | Details |
| NGM-386 | NGM-386 | Phase 1 Clinical | Ngm Biopharmaceuticals Inc | Obesity | Details |
| NGM-395 | NGM-395 | Phase 1 Clinical | Ngm Biopharmaceuticals Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity | Details |

BettinastraBe 30, 60325 Frankfurt am Main



